Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petra Brhlikova

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Social Science & Medicine (1982)|March 31, 2015
Social networks and health policy: the case of misoprostol and the WHO model essential medicine listColin Millard, Petra Brhlikova, Allyson Pollock
Journal of the Royal Society of Medicine|January 6, 2011
Global Burden of Disease estimates of depression--how reliable is the epidemiological evidence?Petra Brhlikova, Allyson M Pollock, Rachel Manners
Journal of the Royal Society of Medicine|January 22, 2020
Will HPV vaccination prevent cervical cancer?Claire P Rees, Petra Brhlikova, Allyson M Pollock
BMC Public Health|August 23, 2016
Prescribing indicators at primary health care centers within the WHO African region: a systematic analysis (1995-2015)Richard Ofori-Asenso, Petra Brhlikova, Allyson M Pollock
Journal of the Royal Society of Medicine|August 22, 2012
Rethinking WHO guidance: review of evidence for misoprostol use in the prevention of postpartum haemorrhageChristina S Chu, Petra Brhlikova, Allyson M Pollock
Bulletin of the World Health Organization|August 11, 2020
Registration of antimicrobials, Kenya, Uganda and United Republic of Tanzania, 2018Rosanna Lyus, Allyson Pollock, Moses Ocan, et al.
Bulletin of the World Health Organization|January 9, 2025
Establishing links between drug registers and essential medicines listsPetra Brhlikova, Zaheer-Ud-Din Babar, Allyson M Pollock
Plos Medicine|September 11, 2019
The use of validated and nonvalidated surrogate endpoints in two European Medicines Agency expedited approval pathways: A cross-sectional study of products authorised 2011-2018Catherine Schuster Bruce, Petra Brhlikova, Joseph Heath, et al.
JRSM Open|April 1, 2024
Audit of essential medicine listing and registration status of medicines on standard treatment guidelines in Kenya, Tanzania and Uganda: Case study of malaria, tuberculosis, hypertension and type 2 diabetes mellitusDeborah Babatunde, Allyson M Pollock, Moses Ocan, et al.
JRSM Open|January 15, 2024
A critical appraisal of the quality of data submitted by sub-Saharan African cancer registries to GLOBOCAN 2020Ereel Ayubi, Rosanna Lyus, Petra Brhlikova, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Social Science & Medicine (1982)|March 31, 2015
Social networks and health policy: the case of misoprostol and the WHO model essential medicine listColin Millard, Petra Brhlikova, Allyson Pollock
Journal of the Royal Society of Medicine|January 6, 2011
Global Burden of Disease estimates of depression--how reliable is the epidemiological evidence?Petra Brhlikova, Allyson M Pollock, Rachel Manners
Journal of the Royal Society of Medicine|January 22, 2020
Will HPV vaccination prevent cervical cancer?Claire P Rees, Petra Brhlikova, Allyson M Pollock
BMC Public Health|August 23, 2016
Prescribing indicators at primary health care centers within the WHO African region: a systematic analysis (1995-2015)Richard Ofori-Asenso, Petra Brhlikova, Allyson M Pollock
Journal of the Royal Society of Medicine|August 22, 2012
Rethinking WHO guidance: review of evidence for misoprostol use in the prevention of postpartum haemorrhageChristina S Chu, Petra Brhlikova, Allyson M Pollock
Bulletin of the World Health Organization|August 11, 2020
Registration of antimicrobials, Kenya, Uganda and United Republic of Tanzania, 2018Rosanna Lyus, Allyson Pollock, Moses Ocan, et al.
Bulletin of the World Health Organization|January 9, 2025
Establishing links between drug registers and essential medicines listsPetra Brhlikova, Zaheer-Ud-Din Babar, Allyson M Pollock
Plos Medicine|September 11, 2019
The use of validated and nonvalidated surrogate endpoints in two European Medicines Agency expedited approval pathways: A cross-sectional study of products authorised 2011-2018Catherine Schuster Bruce, Petra Brhlikova, Joseph Heath, et al.
JRSM Open|April 1, 2024
Audit of essential medicine listing and registration status of medicines on standard treatment guidelines in Kenya, Tanzania and Uganda: Case study of malaria, tuberculosis, hypertension and type 2 diabetes mellitusDeborah Babatunde, Allyson M Pollock, Moses Ocan, et al.
JRSM Open|January 15, 2024
A critical appraisal of the quality of data submitted by sub-Saharan African cancer registries to GLOBOCAN 2020Ereel Ayubi, Rosanna Lyus, Petra Brhlikova, et al.
Pageof 3